With the functional dichotomy of IL-1β and T1-IFNs in mind, as shown in Figure 2, MS and SLE seem to be opposite ends of the disease spectrum in AID instead of demonstrating interactions between T1-IFNs and the Th17 response. This evidence concerns the gene IL1B and myeloid sarcoma.